Filana Therapeutics Financials - Benzinga

Filana Therapeutics Inc

FLNANASDAQ

Trade with Public

Trade with Public

$0.6965

-0.0223-3.1%

At close: Sep 14, 5:00 PM EST

$0.7000

-0.0188-2.62%

Pre-Market: 4:00 AM EST

Overview News Earnings Forecast Price TargetsFinancialsSentiment Compare Options Stock Report

Filana Therapeutics Financials

Filana Therapeutics (FLNA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Filana Therapeutics Q2 EPS $(0.18) Beats $(0.23) Estimate

Filana Therapeutics (NASDAQ:FLNA) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.23) by 18.18 percent. This is a 80.43 percent increase over losses of $(0.92) per share

Benzinga Newsdesk

PRO
Filana Therapeutics Q1 EPS $(0.21) Beats $(0.23) Estimate

Filana Therapeutics (NASDAQ:FLNA) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.23) by 8.7 percent. This is a 56.25 percent increase over losses of $(0.48) per share from

Benzinga Newsdesk